Growing community of inventors

Philadelphia, PA, United States of America

Mark Mendonca

Average Co-Inventor Count = 11.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 4

Mark MendoncaAlexey Teplyakov (3 patents)Mark MendoncaRicardo Attar (3 patents)Mark MendoncaFrancois Gaudet (3 patents)Mark MendoncaMark Tornetta (3 patents)Mark MendoncaYingzhe Li (3 patents)Mark MendoncaSuzanne Edavettal (3 patents)Mark MendoncaNathan Majewski (3 patents)Mark MendoncaKodandaram Pillarisetti (3 patents)Mark MendoncaLeopoldo L Luistro, Iii (3 patents)Mark MendoncaDiana Chin (3 patents)Mark MendoncaLeopoldo Luistro (1 patent)Mark MendoncaKondandaram Pillarisetti (0 patent)Mark MendoncaMark Mendonca (3 patents)Alexey TeplyakovAlexey Teplyakov (32 patents)Ricardo AttarRicardo Attar (24 patents)Francois GaudetFrancois Gaudet (11 patents)Mark TornettaMark Tornetta (9 patents)Yingzhe LiYingzhe Li (6 patents)Suzanne EdavettalSuzanne Edavettal (5 patents)Nathan MajewskiNathan Majewski (4 patents)Kodandaram PillarisettiKodandaram Pillarisetti (4 patents)Leopoldo L Luistro, IiiLeopoldo L Luistro, Iii (3 patents)Diana ChinDiana Chin (3 patents)Leopoldo LuistroLeopoldo Luistro (1 patent)Kondandaram PillarisettiKondandaram Pillarisetti (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Janssen Pharmaceutica Nv (2 from 2,078 patents)

2. Janssen Biotech, Inc. (1 from 410 patents)


3 patents:

1. 11884722 - Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof

2. 11685777 - Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof

3. 10562968 - Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/26/2025
Loading…